Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stage
Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stage expansion opportunities. The firm does not invest in research based pharmaceutical, vaccine, and biotechnology companies. It seeks to invest in private Internet, commercialization, distribution and delivery of pharmaceuticals, and health care services. The firm typically invests in companies based in the United States and also considers non-United States companies with significant United States operations. It typically invests between $3 million and $8 million. The firm seeks to co-invest and prefers a board representation in its portfolio companies. It also seeks to provide follow-on financing. Merck Capital Ventures, LLC was founded in November 2000 and is based in Woodcliff Lake, New Jersey. Merck Capital Ventures, LLC operates as an investment arm of Merck & Co. Inc.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 13, 2011
HTG Molecular Diagnostics
|
Series D | $16.20M | Biotechnology | — |
Nov 28, 2008
HTG Molecular Diagnostics
|
Series C | $2.80M | Biotechnology | — |
Oct 8, 2007
HTG Molecular Diagnostics
|
Series C | $5.61M | Biotechnology | — |